Are Angiotensin II Receptor Blockers Really Safe From Aminotransferase Elevation or Drug-Induced Liver Injury?
Jang BK.
J Korean Med Sci. 2022 Aug 22;37(33):e261. doi: 10.3346/jkms.2022.37.e261.
Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions.
Carlson GS, Wong PH, White KM, Quinn JM.
J Allergy Clin Immunol Pract. 2017 Sep-Oct;5(5):1430-1432. doi: 10.1016/j.jaip.2017.05.009. Epub 2017 Jul 8.
Les enjeux de la surcharge hydro-sodée.
Vrtovsnik F, Fartoux L.
Nephrol Ther. 2016 Dec;12(7S):S10-S11. doi: 10.1016/S1769-7255(17)30020-2.
Spironolactone-potion or poison?
[No authors listed]
Drug Ther Bull. 2017 Feb;55(2):13. doi: 10.1136/dtb.2017.2.0452. Epub 2017 Feb 2.
The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.
Flaten HK, Monte AA.
Cardiovasc Drugs Ther. 2017 Aug;31(4):471-482. doi: 10.1007/s10557-017-6733-2.
Losartan-induced hepatotoxicity.
Bosch X.
JAMA. 1997 Nov 19;278(19):1572.
Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study.
Cheung ECL, Adesuyan M, Szilcz M, Kalisch Ellett LM, Shah S, Jani YH, Hägg S, Pratt N, Lau KK, Luo H, Wan EYF, Chan EWY, Wong ICK, Yuen JK, Yiu KH, Howard R, Brauer R, Chui CSL.
Age Ageing. 2025 May 3;54(5):afaf121. doi: 10.1093/ageing/afaf121.
Unintentional paediatric ingestions of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists.
Balit CR, Gilmore SP, Isbister GK.
J Paediatr Child Health. 2007 Oct;43(10):686-8. doi: 10.1111/j.1440-1754.2007.01188.x.
The potential therapeutic use of renin-angiotensin system inhibitors in the treatment of inflammatory diseases.
Ranjbar R, Shafiee M, Hesari A, Ferns GA, Ghasemi F, Avan A.
J Cell Physiol. 2019 Mar;234(3):2277-2295. doi: 10.1002/jcp.27205. Epub 2018 Sep 7.
Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs.
Chen VL, Rockey DC, Bjornsson ES, Barnhart H, Hoofnagle JH; Drug-Induced Liver Injury Network Investigators.
Drug Saf. 2025 Feb;48(2):151-160. doi: 10.1007/s40264-024-01486-6. Epub 2024 Sep 24.
